Close
Smartlab Europe
Achema middle east

Tag: Pharmaceuticals

Laboratory Safety Equipment and Infrastructure in High-Potency Drug Handling

Understanding the critical role of containment isolators, biosafety cabinets, and specialized infrastructure in protecting operators and maintaining product integrity during high-potency API manufacturing requires examining regulatory frameworks, engineering controls, and facility design principles that define modern pharmaceutical safety standards.

Modular and Portable Laboratory Equipment Supporting Flexible Pharma Operations

Modern pharmaceutical manufacturing demands adaptable infrastructure capable of rapid reconfiguration to accommodate changing production requirements, making modular and portable laboratory equipment essential for contract manufacturers, clinical trial operations, and organizations pursuing capacity expansion through scalable platform technologies.

Cold Chain and Temperature-Controlled Laboratory Equipment in Pharmaceutical Research and Development

Temperature-sensitive biologics, advanced therapeutics, and pharmaceutical research materials demand specialized cold storage infrastructure spanning ultra-low temperature freezers, controlled-rate freezing systems, and validated stability chambers that maintain precise thermal conditions throughout research, development and testing workflows.

CMS Unveils a New Voluntary Access Programme For GLP-1

In the most recent of a string of announcements ahead of the holiday season, Centers for Medicare & Medicaid Services (CMS) has unveiled a new...

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50 per share cash tender offer when it comes to Emeryville, California-based vaccine developer Dynavax, which...

Samsung Biologics to Buy US Drug Plant from GSK for $280M

On December 22, 2025, the news has been confirmed of Samsung Biologics to Buy US Drug Plant which is going to be its first...

New Agreements with Pharmaceuticals Target Lower U.S. Drug Prices

President Donald Trump on December 19, 2025, said that his administration has reached agreements with nine additional pharmaceutical companies, therefore extending a campaign that...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »